40 related articles for article (PubMed ID: 34629256)
1. Role of Angiotensin II in Non-Alcoholic Steatosis Development.
Alvarado-Ojeda ZA; Trejo-Moreno C; Ferat-Osorio E; Méndez-Martínez M; Fragoso G; Rosas-Salgado G
Arch Med Res; 2024 Apr; 55(3):102986. PubMed ID: 38492325
[TBL] [Abstract][Full Text] [Related]
2. Review article: Hepatic steatosis and its associations with acute and chronic liver diseases.
Koenig AB; Tan A; Abdelaal H; Monge F; Younossi ZM; Goodman ZD
Aliment Pharmacol Ther; 2024 Jun; ():. PubMed ID: 38845486
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial Dysfunction-Associated Mechanisms in the Development of Chronic Liver Diseases.
Arumugam MK; Gopal T; Kalari Kandy RR; Boopathy LK; Perumal SK; Ganesan M; Rasineni K; Donohue TM; Osna NA; Kharbanda KK
Biology (Basel); 2023 Oct; 12(10):. PubMed ID: 37887021
[TBL] [Abstract][Full Text] [Related]
4. Adverse outcome pathway-based analysis of liver steatosis in vitro using human liver cell lines.
Karaca M; Fritsche K; Lichtenstein D; Vural Ö; Kreuzer K; Alarcan J; Braeuning A; Marx-Stoelting P; Tralau T
STAR Protoc; 2023 Sep; 4(3):102500. PubMed ID: 37616165
[TBL] [Abstract][Full Text] [Related]
5. Letter: Are we forgetting the importance of steatosis in steatotic liver disease?
Fiori J; Ayonrinde OT
Aliment Pharmacol Ther; 2024 Jan; 59(2):295-296. PubMed ID: 38153283
[No Abstract] [Full Text] [Related]
6. Letter: Are we forgetting the importance of steatosis in steatotic liver disease? Authors' reply.
Kuo SZ; Loomba R
Aliment Pharmacol Ther; 2024 Jan; 59(2):297-298. PubMed ID: 38153275
[No Abstract] [Full Text] [Related]
7. Endothelial Cell Dysfunction and Nonalcoholic Fatty Liver Disease (NAFLD): A Concise Review.
Nasiri-Ansari N; Androutsakos T; Flessa CM; Kyrou I; Siasos G; Randeva HS; Kassi E; Papavassiliou AG
Cells; 2022 Aug; 11(16):. PubMed ID: 36010588
[TBL] [Abstract][Full Text] [Related]
8. Modulation of hepatic steatosis by dietary fatty acids.
Ferramosca A; Zara V
World J Gastroenterol; 2014 Feb; 20(7):1746-55. PubMed ID: 24587652
[TBL] [Abstract][Full Text] [Related]
9. Extent and features of liver steatosis in vitro pave the way to endothelial dysfunction without physical cell-to-cell contact.
Baldini F; Khalil M; Serale N; Voci A; Portincasa P; Vergani L
Nutr Metab Cardiovasc Dis; 2021 Nov; 31(12):3522-3532. PubMed ID: 34629256
[TBL] [Abstract][Full Text] [Related]
10. Adipocyte-hepatocyte crosstalk in cellular models of obesity: Role of soluble factors.
Baldini F; Diab F; Serale N; Zeaiter L; Portincasa P; Diaspro A; Vergani L
Life Sci; 2023 Mar; 317():121464. PubMed ID: 36731646
[TBL] [Abstract][Full Text] [Related]
11. Cooperation of liver cells in health and disease.
Kmieć Z
Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
[TBL] [Abstract][Full Text] [Related]
12. Biomechanics of cultured hepatic cells during different steatogenic hits.
Baldini F; Bartolozzi A; Ardito M; Voci A; Portincasa P; Vassalli M; Vergani L
J Mech Behav Biomed Mater; 2019 Sep; 97():296-305. PubMed ID: 31151002
[TBL] [Abstract][Full Text] [Related]
13. Silybin counteracts lipid excess and oxidative stress in cultured steatotic hepatic cells.
Vecchione G; Grasselli E; Voci A; Baldini F; Grattagliano I; Wang DQ; Portincasa P; Vergani L
World J Gastroenterol; 2016 Jul; 22(26):6016-26. PubMed ID: 27468193
[TBL] [Abstract][Full Text] [Related]
14. New Perspectives of S-Adenosylmethionine (SAMe) Applications to Attenuate Fatty Acid-Induced Steatosis and Oxidative Stress in Hepatic and Endothelial Cells.
Vergani L; Baldini F; Khalil M; Voci A; Putignano P; Miraglia N
Molecules; 2020 Sep; 25(18):. PubMed ID: 32942773
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
